Up to a fifth of patients with colorectal cancer (CRC) present with synchronous hepatic
metastases. In patients with CRC who present without intestinal obstruction or perforation …

Background In recent years, the management of synchronous colorectal liver metastasis has
changed significantly. Alternative surgical strategies to the classical colorectal‐first approach …

Background Colorectal cancer is the third most common and the third most lethal cancer in
both men and women in developed countries. About 75% of cases are first diagnosed when …

INTRODUCTION: The traditional surgical management for patients presenting with
synchronous colorectal liver metastases (SCLM) has been a delayed resection. However, in …

Introduction: With the advent of multidisciplinary and multimodality approaches to the
management of colorectal cancer patients, there is an increasing need to define how we …

Purpose To evaluate long-term outcome and toxicity of stereotactic body radiation therapy
(SBRT) for hepatic oligometastases from solid tumors. Methods and materials Eligible …

HER-3 (also known as ErbB-3) is a human epidermal growth factor receptor tyrosine kinases
family member, and its expression in CRC (colorectal cancer) tissues was previously …

Objectives This study evaluated the predictive role of 1D, 2D and 3D quantitative,
enhancement-based MRI regarding overall survival (OS) in patients with colorectal liver …

Forty to fifty percent of colorectal cancer (CRC) patients develop colorectal liver metastases
(CLM) that are either synchronous or metachronous in presentation. Clarifying whether there …

Purpose To determine if lower-dose computed tomographic (CT) scans obtained with
adaptive image-based noise reduction (adaptive nonlocal means [ANLM]) or iterative …